Physician profile
Robert E Fox
NPI 1962431387
$1,644.53
in general payments reported to CMS, 2019-2025
26 companies · $178 in 2025
The $178 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $837 · 2022: $481 · 2023: $29.32 · 2024: $119 · 2025: $178.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $326.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $326.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $250.54 | 2021-2025 | Inceptiv |
| Boston Scientific Corporation | $243.17 | 2021-2025 | General - Pain Management, Wavewriter Alpha Prime 16, Bionic Navigator |
| Abbvie INC. | $186.08 | 2021-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $110.77 | 2022 | |
| Lilly USA, LLC | $94.38 | 2021-2022 | |
| Biodelivery Sciences International, INC. | $85.97 | 2021 | |
| Protega Pharmaceutials INC | $79.81 | 2025 | Roxybond |
| Biohaven Pharmaceuticals, INC. | $55.34 | 2021 | |
| Allergan, INC. | $52.46 | 2021 | |
| Amgen INC. | $49.82 | 2021-2022 | |
| Pfizer INC. | $44.63 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $42.56 | 2021-2025 | Relistor |
| Scilex Pharmaceuticals INC. | $41.95 | 2021-2022 | |
| Lundbeck LLC | $36.66 | 2022 | |
| Bioventus LLC | $35.85 | 2022-2024 | Gelsyn-3 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spr Therapeutics, INC | $32.19 | 2022 | |
| Vertos Medical, INC. | $28.93 | 2024 | Mild Device Kit |
| Ibsa Pharma INC. | $24.12 | 2021 | |
| Ultragenyx Pharmaceutical INC. | $22.90 | 2021 | |
| Redhill Biopharma INC. | $21.93 | 2021 | |
| Horizon Therapeutics Plc | $21.14 | 2022 | |
| Valinor Pharma, LLC | $18.42 | 2025 | Movantik |
| Baudax Bio INC. | $17.55 | 2021 | |
| Curonix LLC | $16.86 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Nevro Corp. | $15.49 | 2022 | |
| Almatica Pharma LLC | $15.01 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Fox listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.